Eversheds Ireland plays key role in the takeover of Paladin Labs by Endo Health
Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.
In this transaction, the acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target.
An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
From October 2014, renewable energy projects will compete for a budget of more than £200m a year as part of the first allocation round for the new contracts for difference.
There should be a market investigation into the markets for banking services for SMEs and the supply of personal current accounts, according to the CMA.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe